Related Experiment Videos
Coinfection with HIV and HCV: more questions than answers?
T W Waldrep1, K K Summers, P A Chiliade
1South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Immunosuppression Clinic, San Antonio, USA.
Insights
Hepatitis C virus (HCV) coinfection accelerates liver disease in patients with human immunodeficiency virus (HIV). Limited data exist on treating HCV in these coinfected individuals, posing a significant public health challenge.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Chronic hepatitis C virus (HCV) infection is a global health concern.
- Human immunodeficiency virus (HIV)-infected individuals share transmission routes with HCV, leading to coinfection.
- HCV/HIV coinfection increases risks of liver cirrhosis, end-stage liver disease, and liver cancer, contributing to morbidity and mortality.
Purpose of the Study:
- To highlight the increased risk of severe liver disease in HCV/HIV coinfected patients.
- To underscore the impact of longer survival with HIV on HCV-related complications.
- To identify the limited data on HCV treatment in coinfected populations.
Main Methods:
- Review of existing literature on HCV/HIV coinfection.
- Analysis of the impact of highly active antiretroviral therapy (HAART) on HIV progression.
- Assessment of the progression of chronic HCV in the context of HIV coinfection.
Main Results:
- HIV survival has improved due to HAART, increasing the risk of long-term HCV sequelae.
- HIV coinfection may accelerate the progression of chronic HCV infection.
- The effect of HCV on HIV disease progression remains unclear.
- Data on treating HCV in coinfected patients are scarce.
Conclusions:
- HCV/HIV coinfection presents a complex clinical challenge with increased liver disease burden.
- Further research is needed to understand the interaction between HCV and HIV and to develop effective treatment strategies for coinfected patients.
Abstract:
Chronic infection with the hepatitis C virus (HCV) is a major public health threat in the United States and worldwide. By sharing some routes of transmission, persons infected with the human immunodeficiency virus (HIV) are at risk for coinfection with HCV As a result, hepatic cirrhosis, end-stage liver disease, and hepatocellular carcinoma due to chronic infection with HCV are important causes of both morbidity and mortality in coinfected patients. The advent of highly active antiretroviral therapy improved the management of patients with HIV, leading to decreased morbidity and better survival. As patients infected with HIV live longer, their risk of long-term sequelae from chronic HCV increases. Coinfection with HIV may be associated with rapid progression of chronic HCV. In contrast, the effect of HCV on the natural history of HIV is less clear. Data regarding treatment of HCV in HIV-coinfected patients are limited.